Year of referral | Combined | |||
---|---|---|---|---|
2017 | 2018 | 2019 | ||
Age (yrs), median (IQR) | 58 (42, 70) | 58 (42, 71) | 55 (38, 68) | 57 (41, 70) |
Females, % (n) | 49% (1202) | 52% (1146) | 51% (1257) | 51% (3605) |
Indication for HiTH, % (n) | ||||
IV medications | 81% (2006) | 76% (1671) | 76% (1875) | 78% (5552) |
Post-op drain | 10% (243) | 12% (257) | 12% (289) | 11% (789) |
Rehab in the home | 3% (67) | 6% (125) | 6% (142) | 5% (334) |
Bridging therapy | 3% (84) | 5% (99) | 3% (78) | 4% (261) |
IP medications | 2% (43) | 1% (23) | 1% (34) | 1% (100) |
Other (NP review etc.) | 1% (23) | 1% (20) | 2% (39) | 1% (82) |
Length of treatment (days), median (IQR) | 7 (4,17) | 7 (4,18) | 7 (4,15) | 7 (4, 16) |
Presentation to ED, % (n) | 3% (84) | 2% (45) | 2% (43) | 2% (172) |